Europe - Belgium

Deloitte

More informationMore information

Deloitte Legal is is capable of advising both private equity and venture capital investors as well as a large roster of start-up and scale-up clients on buy- and sell-side M&A, focusing in particular on early-stage investments and mid-market acquisitions. The firm regularly also regularly leverages its internal tax and financial advisory capabilities to provide its clients with comprehensive regulatory advice. David Roelens, Christoph Michiels, and Marc Van tieghem jointly lead the team and handle acquisitions, sales, and investments in a broad range of sectors. Tim Baart left the practice in December 2022, while Benoît Féron departed in May 2023.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Very involved, hands-on team.’

  • ‘Marc Van tieghem and Hans Vansweevelt deliver extremely good work and go the extra mile to get things done. ’

  • ‘Hands-on; excellent legal knowledge.’

Key clients

  • PMV - Welvaartsfonds
  • Baltisse
  • Waterland
  • Saffelberg
  • D’Ieteren
  • Chequers Capital
  • Aurelius
  • Kebek Private Equity
  • De Eik NV
  • Forbion
  • Imec.Xpand Comm.V.
  • Jeito
  • Inkef Capital
  • Welvaartsfonds
  • Vbio-Ventures
  • Agomab Therapeutics NV
  • Amber Technologies
  • Arkite NV
  • Aphea NV
  • Apitope International NV
  • Arcsec NV
  • Augustine Therapeutics NV
  • Bioqube Ventures NV
  • Bubbly-Doo BV
  • Beeple NV
  • Complix NV
  • Constell8 NV
  • Deuteroncology NV
  • Dualyx NV
  • Epigan NV
  • eTheRNA Immunotherapies NV
  • FOx Biosystems NV
  • Friedewald Confectionary NV
  • Inbiose NV
  • Indigo Diabetes NV
  • Intigriti NV
  • Jay Technologies
  • Micledi Microdisplays BV
  • Minoryx Therapeutics BE NV
  • MRM Technologies NV
  • MRM Health NV
  • Ontoforce NV
  • Ovizio Imaging Systems NV
  • Primmune
  • Prodigest BV
  • Protealis NV
  • Rewind Therapeutics NV
  • S-biomedic NV
  • Sensolus NV
  • Sentea NV
  • Softhale NV
  • Solithor BV
  • Swave BV
  • Trince BV
  • Unifly NV
  • Vipun Medical NV

Work highlights

  • Assisted Aphea.Bio with its Series C investment round of approx. €70m and closing of the first tranche capital increase of approximately €25m.
  • Advised the H. Essers Family Office on its acquisition of the solar panel company Extra Power and the reinvestment by the existing management in the acquisition vehicle.

Practice head

The lawyer(s) leading their teams.

David Roelens, Christoph Michiels, Marc Van tieghem

Other key lawyers

Henri-Simon Vande Vyver, Hans Vansweevelt